Home
About us
Research & Technology
News
Careers
Contact

Research & Technology

The cMet Target

cMet receptor

The cMet Targeted Agents Platform

About Us

Edinburgh Molecular develops a versatile and disease focused approach to imaging and therapeutic compounds development.

Edinburgh Molecular Imaging

Nine
9 Little France Road
Edinburgh BioQuarter (Gate 3)
Edinburgh EH16 4UX
United Kingdom

Recent News

Exceptional growth for Venture Capital Deals in radiopharmaceutical companies in 2023

8 Dec 2023 | Misc, Radiopharmaceutical Therapy

Dr Lena Unterrainer presents data on [Ga-68]EMP-100 at EANM 2023

12 Sep 2023 | [Ga-68]EMP-100, Collaborations, Radiopharmaceutical Therapy

Results published by Investigator on non-invasive assessment of c-MET expression in non-small cell lung cancer

1 Mar 2023 | [Ga-68]EMP-100, Collaborations

Press Releases
Privacy Policy

Edinburgh Molecular Imaging – 2024